Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Abbott Point of Care (APOC) is a global leader in the development and manufacturing of handheld medical diagnostic products designed for rapid blood analysis at the patient's bedside. The company's flagship product, the i-STAT System, is a portable blood analyzer that provides lab-quality results within minutes using only a few drops of blood. APOC's technology facilitates real-time clinical decision-making across various settings, including emergency departments, intensive care units, and remote rural clinics. Their diagnostic menu covers a broad range of tests, including cardiac markers, blood gases, electrolytes, and specialized assays like the i-STAT TBI Plasma test for traumatic brain injury. As a division of Abbott, APOC leverages extensive global manufacturing and distribution networks to serve healthcare providers in over 150 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on APOC.